Creasallis is a startup based in the United Kingdom, most recent round Seed, 1 tracked investor.
Creasallis is a startup based in the United Kingdom. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Creasallis develops CreaTap, a patented antibody engineering technology that enhances penetration of antibody-based therapeutics into solid tumors to improve efficacy in cancer treatment.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.